Weave is excited  to be participating in AGENT 2025, the premier global conference for translational medicine and AI in drug discovery and development. The conference brings together leaders from academia, industry, and regulatory agencies to explore the responsible deployment of AI across the therapeutic pipeline—from target identification to clinical trials.

Location: InterContinental Boston, Boston, MA
Dates: May 6–7, 2025
More Information: agentconference.com

Representing Weave at AGENT 2025:
Ari Caroline, CEO
Ari will serve as Session Chair for one of the afternoon tracks, guiding discussions at the intersection of AI innovation and regulatory rigor.

Umut Eser, CIAO
Umut will join a panel titled "Building Trust in AI: Validation and Transparency in Drug Development" alongside fellow experts from across the industry. The panel will examine approaches to building confidence in AI systems—balancing innovation with reproducibility, traceability, and alignment with evolving regulatory expectations.

Panel Details:

Date: Tuesday, May 6, 2025
Time: 3:15 PM EDT
Location: AGENT 2025 Main Stage

Why Attend this Session?

• Gain insight into how AI is being validated in real-world drug development workflows
• Explore strategies for transparency and traceability across AI-enabled platforms
• Hear from AI leaders on navigating the evolving regulatory and ethical landscape

If you’re attending AGENT 2025 and are exploring how AI can support safe, scalable innovation in drug development, we’d love to connect with you.

‍